Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. May 15, 2026; 18(5): 116764
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.116764
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.116764
Table 3 Multivariate Cox regression analysis of recurrence-free survival
| Characteristics | HR (95%CI) | P value |
| Age, years | 0.982 (0.969-0.995) | 0.007 |
| Macrovascular invasion, positive | 1.621 (1.156-2.271) | 0.005 |
| Tumor diameter, cm | 1.048 (1.011-1.087) | 0.011 |
| Tumor number, multiple | 1.937 (1.466-2.560) | < 0.001 |
| Tumor component proportion, balanced | 1.706 (1.216-2.393) | 0.002 |
| Tumor component proportion, CCA-dominant | 1.524 (1.101-2.109) | 0.011 |
| MVI, positive | 1.685 (1.292-2.197) | < 0.001 |
| PNI, positive | 1.445 (1.027-2.035) | 0.035 |
| Hepatic steatosis, severe | 0.614 (0.383-0.984) | 0.043 |
- Citation: Wang H, Cao ZY, Xia CY, Sheng X, Zhao Y, Chen HZ, Cong WM, He MX, Dong H. Severe hepatic steatosis as a protective prognostic factor in combined hepatocellular-cholangiocarcinoma: A multicenter pathological study. World J Gastrointest Oncol 2026; 18(5): 116764
- URL: https://www.wjgnet.com/1948-5204/full/v18/i5/116764.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i5.116764